Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Judith Regensteiner

Concepts (530)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intermittent Claudication
46
2022
118
5.110
Why?
Diabetes Mellitus, Type 2
54
2024
2518
4.510
Why?
Sex Characteristics
18
2024
759
3.440
Why?
Peripheral Arterial Disease
24
2022
473
3.330
Why?
Exercise
47
2024
2043
3.260
Why?
Exercise Therapy
31
2022
436
2.950
Why?
Peripheral Vascular Diseases
25
2011
103
2.560
Why?
Sex Factors
20
2024
2060
2.290
Why?
Oxygen Consumption
33
2021
695
2.120
Why?
Cardiovascular Diseases
23
2024
2104
1.980
Why?
Walking
23
2022
523
1.940
Why?
Diabetes Mellitus
18
2024
1032
1.900
Why?
Women's Health
10
2024
369
1.780
Why?
Biomedical Research
8
2024
688
1.470
Why?
Exercise Test
38
2019
625
1.420
Why?
Cardiology
6
2023
274
1.210
Why?
Exercise Tolerance
15
2024
279
1.170
Why?
American Heart Association
10
2019
306
1.140
Why?
Quality of Life
18
2019
2878
1.090
Why?
Leg
13
2021
236
1.050
Why?
Research Personnel
5
2024
171
1.040
Why?
Humans
184
2024
136764
0.930
Why?
Mentoring
3
2022
144
0.880
Why?
Adverse Drug Reaction Reporting Systems
1
2024
77
0.880
Why?
United States Food and Drug Administration
1
2024
208
0.840
Why?
Diabetic Angiopathies
6
2017
259
0.840
Why?
Vascular Stiffness
3
2023
493
0.820
Why?
Female
106
2024
72787
0.800
Why?
Muscle, Skeletal
14
2024
1710
0.800
Why?
Male
101
2024
67309
0.780
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2024
443
0.770
Why?
Community Health Services
2
2015
227
0.770
Why?
Cardiovascular System
5
2023
137
0.770
Why?
Diabetic Cardiomyopathies
3
2016
36
0.760
Why?
Education, Medical
3
2020
260
0.750
Why?
Periodicals as Topic
1
2024
208
0.740
Why?
Insulin Resistance
12
2024
1203
0.700
Why?
Lower Extremity
9
2019
423
0.680
Why?
Arterial Occlusive Diseases
7
2015
80
0.670
Why?
Interdisciplinary Research
1
2020
27
0.660
Why?
Aged
57
2024
23794
0.630
Why?
Cardiorespiratory Fitness
2
2019
55
0.630
Why?
Middle Aged
73
2024
33228
0.630
Why?
Endothelium, Vascular
6
2021
926
0.620
Why?
Sitagliptin Phosphate
1
2019
33
0.620
Why?
Obesity
19
2023
2982
0.620
Why?
Diastole
1
2019
149
0.600
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2019
46
0.600
Why?
Surveys and Questionnaires
23
2018
5742
0.580
Why?
United States
37
2024
14691
0.570
Why?
Physical Fitness
9
2016
208
0.570
Why?
Gender Identity
1
2019
124
0.570
Why?
Hypoglycemic Agents
9
2021
1283
0.560
Why?
Metabolomics
2
2020
678
0.550
Why?
Brachial Artery
6
2015
201
0.540
Why?
Health Status
4
2020
788
0.540
Why?
Mitochondria, Muscle
4
2024
116
0.530
Why?
Hypertension
6
2022
1284
0.530
Why?
Physical Exertion
7
2009
215
0.530
Why?
Venoms
1
2016
29
0.520
Why?
Blood Pressure
12
2021
1774
0.520
Why?
Curriculum
2
2020
976
0.510
Why?
Vasodilator Agents
4
2010
331
0.510
Why?
Biomarkers
6
2024
4143
0.480
Why?
Cardiac Rehabilitation
3
2019
37
0.450
Why?
Research Design
5
2024
1127
0.450
Why?
Life Style
9
2018
487
0.440
Why?
National Institutes of Health (U.S.)
4
2023
128
0.440
Why?
Arteriosclerosis
5
2002
88
0.430
Why?
Sleep
1
2020
753
0.420
Why?
Physicians
5
2024
907
0.410
Why?
Ventricular Dysfunction, Left
1
2016
382
0.410
Why?
Faculty, Medical
6
2024
283
0.410
Why?
Microcirculation
4
2017
146
0.400
Why?
Home Care Services
4
2019
257
0.400
Why?
Diabetes Mellitus, Type 1
9
2024
3710
0.400
Why?
Risk Factors
29
2022
10326
0.390
Why?
Advisory Committees
5
2019
219
0.380
Why?
Mentors
4
2022
200
0.380
Why?
Blood Flow Velocity
4
2009
412
0.370
Why?
Longevity
3
2024
164
0.370
Why?
Adult
40
2024
37630
0.340
Why?
Peptides
1
2016
979
0.340
Why?
Disability Evaluation
2
2011
290
0.340
Why?
Ankle
3
2008
60
0.340
Why?
Weight Loss
6
2016
776
0.330
Why?
Treatment Outcome
24
2022
10744
0.330
Why?
Gait
2
2006
296
0.320
Why?
Regional Blood Flow
11
2020
473
0.310
Why?
Tetrazoles
3
2006
40
0.310
Why?
Cardiac Output, Low
1
2009
66
0.300
Why?
Physical Endurance
3
2011
275
0.300
Why?
Thiazolidinediones
3
2010
137
0.300
Why?
Double-Blind Method
8
2019
1981
0.290
Why?
Oxygen
4
2018
930
0.290
Why?
Research Support as Topic
2
2020
119
0.290
Why?
Recovery of Function
9
2019
652
0.290
Why?
Cost of Illness
3
2018
302
0.290
Why?
Fear
1
2011
338
0.280
Why?
Oxidative Phosphorylation
2
2019
193
0.280
Why?
Follow-Up Studies
9
2024
5106
0.270
Why?
Glucagon-Like Peptide 1
2
2020
133
0.270
Why?
Hematologic Agents
1
2006
2
0.270
Why?
Blood Glucose
10
2024
2181
0.260
Why?
Perception
1
2009
359
0.260
Why?
Activities of Daily Living
5
2021
413
0.260
Why?
Medicare
2
2022
758
0.260
Why?
Caregivers
3
2024
870
0.260
Why?
Stents
6
2015
527
0.250
Why?
Disease Management
4
2017
624
0.240
Why?
Motor Activity
5
2012
717
0.240
Why?
Vascular Diseases
4
2000
243
0.240
Why?
Foundations
2
2018
28
0.240
Why?
Vascular Surgical Procedures
5
2009
299
0.230
Why?
Feasibility Studies
2
2022
951
0.230
Why?
Pharmacovigilance
1
2024
23
0.230
Why?
Interdisciplinary Studies
2
2017
27
0.230
Why?
Societies, Medical
3
2017
816
0.230
Why?
Echocardiography
4
2018
642
0.230
Why?
Troponin
1
2024
50
0.220
Why?
Troponin T
1
2024
65
0.220
Why?
Vasodilation
3
2015
496
0.220
Why?
Respiration
3
1990
199
0.220
Why?
Fibrinolysis
2
2003
143
0.220
Why?
Heart Rate
6
2015
820
0.210
Why?
Insulin
5
2020
2406
0.210
Why?
Troponin I
1
2024
81
0.210
Why?
Overweight
6
2023
557
0.210
Why?
Chest Pain
1
2024
90
0.210
Why?
Medroxyprogesterone
4
1991
11
0.210
Why?
Kinetics
5
2015
1663
0.210
Why?
Pulse Wave Analysis
3
2023
269
0.210
Why?
Lung Diseases
3
2019
767
0.200
Why?
Muscles
7
1994
325
0.200
Why?
Iliac Artery
2
2014
55
0.200
Why?
Minority Groups
2
2022
266
0.200
Why?
Polyhydroxyethyl Methacrylate
1
2002
10
0.200
Why?
Financing, Organized
2
2020
35
0.200
Why?
Financial Management
1
2022
18
0.200
Why?
Phosphodiesterase Inhibitors
1
2002
89
0.190
Why?
Glucose Intolerance
1
2024
146
0.190
Why?
Predictive Value of Tests
5
2017
2022
0.190
Why?
Vitamin E
1
2003
124
0.190
Why?
Orthopedics
1
2024
142
0.190
Why?
Practice Guidelines as Topic
4
2019
1571
0.190
Why?
Endovascular Procedures
2
2018
311
0.190
Why?
Estrogens, Conjugated (USP)
3
1991
49
0.180
Why?
Academic Medical Centers
3
2020
504
0.180
Why?
Congresses as Topic
2
2020
232
0.180
Why?
Ascorbic Acid
1
2003
176
0.180
Why?
Organizational Innovation
2
2020
138
0.180
Why?
Placebos
3
2019
199
0.180
Why?
Arginine
1
2003
271
0.180
Why?
Adiponectin
2
2016
244
0.180
Why?
Interdisciplinary Communication
2
2020
191
0.180
Why?
Severity of Illness Index
4
2009
2822
0.170
Why?
Qualitative Research
3
2024
1366
0.170
Why?
Echocardiography, Doppler
3
2016
108
0.170
Why?
Sulfonylurea Compounds
2
2019
48
0.170
Why?
Sex Distribution
2
2020
373
0.170
Why?
Neovascularization, Physiologic
2
2012
178
0.170
Why?
Precision Medicine
2
2024
426
0.170
Why?
Cardiovascular Agents
2
2014
159
0.160
Why?
Patient Compliance
4
2015
577
0.160
Why?
Time Factors
11
2018
6806
0.160
Why?
Hemodynamics
6
2009
1110
0.160
Why?
Forearm
2
2015
118
0.160
Why?
Arteries
3
2016
269
0.160
Why?
Clinical Trials as Topic
6
2019
1044
0.160
Why?
Case-Control Studies
7
2024
3540
0.160
Why?
Randomized Controlled Trials as Topic
7
2006
1462
0.150
Why?
Pediatric Obesity
2
2017
590
0.150
Why?
Body Composition
5
2014
679
0.150
Why?
Telerehabilitation
1
2019
37
0.150
Why?
Body Mass Index
9
2017
2375
0.150
Why?
Adolescent
12
2022
21382
0.150
Why?
Cross-Sectional Studies
8
2014
5423
0.150
Why?
Cause of Death
1
2020
430
0.140
Why?
Women's Rights
1
2017
4
0.140
Why?
Diabetes Complications
4
2010
226
0.140
Why?
Leadership
2
2020
382
0.140
Why?
Burnout, Professional
1
2024
440
0.140
Why?
Pentoxifylline
3
2006
25
0.140
Why?
Magnetic Resonance Spectroscopy
2
2024
610
0.140
Why?
Health Status Indicators
4
2015
168
0.140
Why?
Aged, 80 and over
9
2012
7585
0.140
Why?
Sexism
1
2018
61
0.140
Why?
Interviews as Topic
4
2024
772
0.140
Why?
Program Development
1
2019
364
0.140
Why?
Death, Sudden, Cardiac
1
2018
185
0.140
Why?
Resistance Training
1
2020
163
0.140
Why?
Heart Diseases
2
2019
346
0.130
Why?
Circadian Rhythm
2
2020
468
0.130
Why?
Colorado
9
2017
4518
0.130
Why?
Ankle Brachial Index
2
2014
37
0.130
Why?
Capillaries
3
2012
108
0.130
Why?
Microvessels
1
2017
85
0.130
Why?
Glucose Tolerance Test
4
2024
364
0.120
Why?
Faculty
1
2017
146
0.120
Why?
Ischemia
1
2019
407
0.120
Why?
Reference Values
4
2007
816
0.120
Why?
Blood Vessels
1
2017
187
0.120
Why?
Needs Assessment
1
2018
372
0.120
Why?
Leptin
1
2017
236
0.120
Why?
Plethysmography
3
2011
106
0.120
Why?
Intention to Treat Analysis
1
2015
73
0.120
Why?
Adiposity
2
2017
518
0.120
Why?
Program Evaluation
2
2020
889
0.120
Why?
Health Status Disparities
1
2018
283
0.110
Why?
Myocardium
1
2020
1001
0.110
Why?
Ventricular Function
1
2015
61
0.110
Why?
Cardiac Output
1
2015
164
0.110
Why?
Physical Education and Training
1
1994
76
0.110
Why?
Pilot Projects
2
2015
1692
0.110
Why?
Endothelium
1
2015
122
0.110
Why?
Oxidative Stress
1
2021
1314
0.110
Why?
Arterial Pressure
1
2015
126
0.110
Why?
Healthy Volunteers
1
2015
199
0.110
Why?
Patient Selection
4
2019
690
0.110
Why?
Peripheral Nervous System Diseases
1
1995
128
0.110
Why?
Health Care Costs
2
2014
384
0.110
Why?
Hyperlipidemias
3
2004
120
0.110
Why?
Hypoxia
3
1990
1112
0.100
Why?
Diagnostic Self Evaluation
1
2013
23
0.100
Why?
Angioplasty
2
2009
47
0.100
Why?
Aortic Diseases
1
2014
117
0.100
Why?
Menopause
3
1991
319
0.100
Why?
Reaction Time
1
2015
412
0.100
Why?
Diet, Reducing
1
2013
89
0.100
Why?
Carnitine
5
2001
84
0.100
Why?
Ventricular Function, Left
1
2016
533
0.100
Why?
Diabetic Nephropathies
2
2014
294
0.090
Why?
Students, Medical
1
2017
339
0.090
Why?
Capacity Building
1
2012
63
0.090
Why?
Retrospective Studies
4
2024
15504
0.090
Why?
Premenopause
2
2003
131
0.090
Why?
Counseling
1
2015
388
0.090
Why?
Smoking
6
2010
1620
0.090
Why?
Myocardial Revascularization
1
2011
73
0.090
Why?
Clinical Protocols
1
1993
267
0.090
Why?
Kidney
2
2021
1467
0.090
Why?
Heart Ventricles
1
2016
785
0.090
Why?
Health Promotion
1
2017
734
0.090
Why?
Linear Models
2
2014
846
0.090
Why?
Research Report
1
2011
83
0.090
Why?
Benchmarking
1
2012
183
0.090
Why?
Sickness Impact Profile
1
2011
56
0.090
Why?
Fatty Acids, Nonesterified
2
2009
159
0.090
Why?
Hemoglobins
2
2017
353
0.090
Why?
Hyperemia
1
2011
49
0.090
Why?
Self Concept
1
2012
249
0.090
Why?
Comorbidity
4
2021
1614
0.090
Why?
Coronary Disease
4
2004
384
0.080
Why?
Consensus
3
2019
678
0.080
Why?
Niacin
1
2010
17
0.080
Why?
Affect
1
2012
292
0.080
Why?
Lovastatin
1
2010
37
0.080
Why?
Atherosclerosis
2
2011
415
0.080
Why?
Hypertrophy, Left Ventricular
2
2009
130
0.080
Why?
Young Adult
6
2024
13129
0.080
Why?
C-Reactive Protein
2
2009
408
0.080
Why?
Platelet Aggregation Inhibitors
3
2002
462
0.080
Why?
Body Fat Distribution
1
2009
49
0.080
Why?
Gonadal Steroid Hormones
1
1990
140
0.080
Why?
Heart Function Tests
1
2009
59
0.080
Why?
Vascular Endothelial Growth Factor A
1
2012
543
0.080
Why?
Hyperinsulinism
2
2010
121
0.080
Why?
Pulmonary Wedge Pressure
1
2009
69
0.080
Why?
Aorta
1
2011
417
0.080
Why?
Thinness
1
2009
91
0.080
Why?
Hospitalization
1
2018
2183
0.070
Why?
Psychometrics
1
2012
719
0.070
Why?
Heart Failure
3
2018
2231
0.070
Why?
Analysis of Variance
4
2012
1316
0.070
Why?
Fasting
2
2005
280
0.070
Why?
Age Factors
4
2021
3284
0.070
Why?
Puberty
1
2009
146
0.070
Why?
Perfusion
1
2009
211
0.070
Why?
Angina Pectoris
1
2008
65
0.070
Why?
Cost-Benefit Analysis
4
2014
587
0.070
Why?
Myoglobin
1
2007
13
0.070
Why?
Leisure Activities
2
2006
32
0.070
Why?
Mitochondria
1
2014
946
0.070
Why?
Inflammation
3
2009
2834
0.070
Why?
Aging
1
2018
1861
0.070
Why?
Awareness
1
2008
102
0.070
Why?
Health Knowledge, Attitudes, Practice
2
2008
1320
0.060
Why?
Prospective Studies
8
2019
7572
0.060
Why?
Prevalence
3
2019
2711
0.060
Why?
Regression Analysis
5
1998
1022
0.060
Why?
Dyspnea
1
2008
254
0.060
Why?
Glycation End Products, Advanced
1
2006
82
0.060
Why?
Chronic Disease
2
2023
1784
0.060
Why?
Blood Viscosity
2
1995
17
0.060
Why?
Metformin
2
2010
330
0.060
Why?
Pulmonary Circulation
1
2007
429
0.060
Why?
Neoplasms
2
2010
2644
0.060
Why?
Glucose Clamp Technique
1
2005
195
0.060
Why?
Hematocrit
2
1995
96
0.060
Why?
Multicenter Studies as Topic
2
2004
308
0.060
Why?
Sulfonic Acids
1
2004
13
0.060
Why?
Interleukin-6
1
2009
778
0.060
Why?
Guilt
1
2024
11
0.060
Why?
Lipids
1
2009
665
0.060
Why?
Animals
5
2018
36823
0.060
Why?
Nutrition Surveys
1
2006
266
0.060
Why?
Population Dynamics
1
1985
149
0.060
Why?
Work-Life Balance
1
2024
21
0.060
Why?
Acetates
1
2004
99
0.050
Why?
Estrogens
2
2010
367
0.050
Why?
Health Maintenance Organizations
1
2004
97
0.050
Why?
Cohort Studies
3
2016
5701
0.050
Why?
Incidence
3
2019
2792
0.050
Why?
Dietary Carbohydrates
1
2004
155
0.050
Why?
Biopsy
3
2012
1124
0.050
Why?
Body Weight
2
2006
985
0.050
Why?
Mitochondrial Diseases
1
2024
91
0.050
Why?
Physicians, Women
1
2024
82
0.050
Why?
Intracranial Arterial Diseases
1
2002
8
0.050
Why?
Genetic Vectors
1
2004
317
0.050
Why?
Dietary Fats
1
2004
304
0.050
Why?
Child
5
2017
21822
0.050
Why?
Neovascularization, Pathologic
1
2004
301
0.050
Why?
Serum Globulins
1
2002
5
0.050
Why?
Glycolysis
1
2024
319
0.050
Why?
Musculoskeletal Diseases
1
2003
77
0.050
Why?
Genetic Therapy
1
2004
293
0.050
Why?
Prognosis
2
2010
4013
0.050
Why?
Lung
1
2015
4052
0.050
Why?
Plasminogen Activator Inhibitor 1
1
2002
86
0.050
Why?
Pelvis
1
2002
102
0.050
Why?
Psychomotor Performance
1
2004
309
0.050
Why?
Single-Blind Method
2
2013
282
0.050
Why?
Ambulatory Care
2
2014
539
0.050
Why?
Fibroblast Growth Factor 2
1
2001
87
0.050
Why?
Proteinuria
1
2001
97
0.040
Why?
Alcohol Drinking
2
2010
820
0.040
Why?
Adipose Tissue
1
2005
630
0.040
Why?
Homocysteine
1
2002
156
0.040
Why?
Diet
2
2010
1274
0.040
Why?
Physical Examination
1
2002
240
0.040
Why?
Patient Satisfaction
2
2002
656
0.040
Why?
Fibrinogen
1
2002
167
0.040
Why?
Enzyme Inhibitors
1
2004
839
0.040
Why?
Aorta, Thoracic
1
2023
267
0.040
Why?
Meta-Analysis as Topic
1
2002
186
0.040
Why?
Cardiovascular Surgical Procedures
1
2000
30
0.040
Why?
Multivariate Analysis
3
2014
1507
0.040
Why?
Altitude
1
1985
485
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
201
0.040
Why?
Administration, Oral
1
2003
813
0.040
Why?
Tissue Plasminogen Activator
1
2002
223
0.040
Why?
Cholesterol, LDL
2
2014
365
0.040
Why?
Myocardial Ischemia
1
2002
262
0.040
Why?
Internal Medicine
1
2002
260
0.040
Why?
Medroxyprogesterone Acetate
2
1990
36
0.040
Why?
Carrier Proteins
1
2004
769
0.040
Why?
Specialties, Surgical
1
2000
74
0.040
Why?
Organization and Administration
1
2019
12
0.040
Why?
Pregnancy
3
2020
6728
0.040
Why?
Femoral Artery
2
2011
179
0.040
Why?
Sports Medicine
2
2010
112
0.040
Why?
Rural Population
2
1995
560
0.040
Why?
Risk Adjustment
1
2019
78
0.040
Why?
Asia
1
2018
70
0.040
Why?
Densitometry
1
1998
36
0.040
Why?
Apoptosis
1
2007
2551
0.040
Why?
Lactic Acid
2
1998
305
0.040
Why?
Patient Outcome Assessment
1
2019
131
0.040
Why?
Hypercapnia
2
1989
53
0.040
Why?
Social Stigma
1
2020
134
0.040
Why?
Coronary Vessels
1
2020
244
0.040
Why?
Walking Speed
1
2018
45
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2001
350
0.040
Why?
Cell Respiration
1
2018
102
0.040
Why?
Autonomic Nervous System
1
1998
75
0.040
Why?
Secondary Prevention
1
2019
232
0.040
Why?
Public Health
1
2023
579
0.040
Why?
Walk Test
1
2018
76
0.030
Why?
Hand Strength
1
2018
122
0.030
Why?
Smoking Cessation
1
2002
436
0.030
Why?
Neural Conduction
2
1995
86
0.030
Why?
Depression
1
2007
1395
0.030
Why?
Capillary Resistance
1
2017
5
0.030
Why?
Pragmatic Clinical Trials as Topic
1
2017
64
0.030
Why?
Drug Therapy, Combination
2
2010
1062
0.030
Why?
Betacoronavirus
1
2020
266
0.030
Why?
Career Choice
1
2019
216
0.030
Why?
Acute Disease
1
2020
1004
0.030
Why?
Oxyhemoglobins
1
2017
23
0.030
Why?
Weight Reduction Programs
1
2018
116
0.030
Why?
Family Practice
1
2001
462
0.030
Why?
Caloric Restriction
1
2018
123
0.030
Why?
Reproducibility of Results
2
2013
3264
0.030
Why?
Spectroscopy, Near-Infrared
1
2017
56
0.030
Why?
Canada
1
2018
417
0.030
Why?
Bicycling
1
2017
114
0.030
Why?
Heart
1
2020
653
0.030
Why?
Forecasting
2
2000
386
0.030
Why?
Sensitivity and Specificity
2
2013
1935
0.030
Why?
Social Support
1
2020
616
0.030
Why?
Vascular Resistance
1
2017
372
0.030
Why?
Stroke Volume
1
2018
612
0.030
Why?
Matched-Pair Analysis
1
1995
39
0.030
Why?
Pneumonia, Viral
1
2020
368
0.030
Why?
Coronavirus Infections
1
2020
358
0.030
Why?
Absorptiometry, Photon
1
2016
254
0.030
Why?
Energy Intake
3
2006
484
0.030
Why?
Risk
1
2017
908
0.030
Why?
Electrophysiology
1
1995
217
0.030
Why?
Cystatin C
1
2014
65
0.030
Why?
Vascular Patency
1
2014
103
0.030
Why?
Quality-Adjusted Life Years
1
2014
113
0.030
Why?
Models, Economic
1
2014
58
0.030
Why?
Life Expectancy
1
2014
68
0.030
Why?
Patient Education as Topic
1
2019
761
0.030
Why?
Phosphorus
1
2014
97
0.030
Why?
Stress, Mechanical
1
2016
481
0.030
Why?
Hospital Costs
1
2014
116
0.030
Why?
Constriction, Pathologic
1
2014
242
0.030
Why?
Databases, Factual
2
2011
1351
0.030
Why?
Drug Costs
1
2014
106
0.030
Why?
Health Behavior
1
2019
756
0.030
Why?
Cyclic AMP Response Element-Binding Protein
1
2014
145
0.030
Why?
Health Education
1
2016
338
0.030
Why?
Nitric Oxide Synthase Type III
1
2014
204
0.030
Why?
Collateral Circulation
2
2003
19
0.030
Why?
Carotid Stenosis
1
2014
91
0.030
Why?
Biomechanical Phenomena
1
2016
806
0.020
Why?
Creatinine
1
2014
499
0.020
Why?
Administrative Personnel
1
2012
29
0.020
Why?
Blood Vessel Prosthesis
1
2013
127
0.020
Why?
Statistics as Topic
1
2013
307
0.020
Why?
Waist Circumference
1
2012
143
0.020
Why?
Evidence-Based Medicine
1
2016
738
0.020
Why?
Internship and Residency
1
2002
1132
0.020
Why?
Treatment Failure
1
2013
354
0.020
Why?
Health Planning
1
1992
47
0.020
Why?
North Carolina
1
2012
107
0.020
Why?
Pandemics
1
2020
1613
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
71
0.020
Why?
Muscle Strength
1
2014
317
0.020
Why?
Muscle Contraction
1
2014
423
0.020
Why?
Popliteal Artery
1
2011
59
0.020
Why?
Cerebrovascular Disorders
1
1992
96
0.020
Why?
Estrone
1
1991
37
0.020
Why?
Behavior Therapy
1
2014
258
0.020
Why?
Radioimmunoassay
1
1991
173
0.020
Why?
Kaplan-Meier Estimate
1
2013
888
0.020
Why?
Glomerular Filtration Rate
1
2014
745
0.020
Why?
Follicular Phase
1
1990
39
0.020
Why?
C-Peptide
1
1991
163
0.020
Why?
Metabolism
1
1990
42
0.020
Why?
Luteal Phase
1
1990
45
0.020
Why?
Incretins
1
2010
22
0.020
Why?
Receptor, IGF Type 1
1
2010
65
0.020
Why?
Receptor, Insulin
1
2010
105
0.020
Why?
Actigraphy
1
2010
110
0.020
Why?
Adaptation, Physiological
1
2014
549
0.020
Why?
Acetylcarnitine
1
1989
5
0.020
Why?
Health Services Research
1
2012
399
0.020
Why?
Percutaneous Coronary Intervention
1
2015
478
0.020
Why?
Progesterone
1
1991
254
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
851
0.020
Why?
Delayed-Action Preparations
1
2010
180
0.020
Why?
Risk Assessment
2
2009
3432
0.020
Why?
Attitude of Health Personnel
1
2017
1163
0.020
Why?
Respiration Disorders
1
1989
77
0.020
Why?
Energy Metabolism
3
2006
919
0.020
Why?
Partial Pressure
1
1988
30
0.020
Why?
Estradiol
1
1991
518
0.020
Why?
Tidal Volume
1
1988
86
0.020
Why?
Drug Interactions
1
1989
407
0.020
Why?
Pain
1
1993
754
0.020
Why?
Ankle Joint
1
2008
114
0.020
Why?
Risk Reduction Behavior
1
2009
218
0.020
Why?
Fluoroquinolones
1
2007
51
0.020
Why?
Caspase 3
1
2007
246
0.020
Why?
Hyperglycemia
1
2010
347
0.020
Why?
Models, Cardiovascular
1
2007
195
0.020
Why?
Testosterone
1
2010
401
0.020
Why?
Longitudinal Studies
1
2014
2829
0.020
Why?
Receptor for Advanced Glycation End Products
1
2006
33
0.020
Why?
Enzyme Activation
1
2007
810
0.020
Why?
Income
1
2007
202
0.020
Why?
Carbon Dioxide
1
1988
267
0.020
Why?
Sleep Wake Disorders
1
1989
283
0.010
Why?
Sterol O-Acyltransferase
1
2004
5
0.010
Why?
Receptors, Immunologic
1
2006
216
0.010
Why?
Acetamides
1
2004
36
0.010
Why?
Case Management
1
2004
66
0.010
Why?
Age Distribution
1
2004
389
0.010
Why?
Cell Adhesion Molecules
1
2004
181
0.010
Why?
Gene Transfer Techniques
1
2004
169
0.010
Why?
Calcium-Binding Proteins
1
2004
218
0.010
Why?
Cognition Disorders
1
2007
495
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2004
382
0.010
Why?
Magnetic Resonance Imaging
1
2014
3555
0.010
Why?
Cytokines
1
2010
2083
0.010
Why?
Endpoint Determination
1
2001
77
0.010
Why?
Lactates
2
1992
85
0.010
Why?
Ultrasonography, Doppler
1
2001
123
0.010
Why?
Sulfonamides
1
2004
513
0.010
Why?
Algorithms
1
2008
1689
0.010
Why?
Attitude
1
2002
259
0.010
Why?
Wound Healing
1
2003
328
0.010
Why?
World Health Organization
1
2000
123
0.010
Why?
Costs and Cost Analysis
1
2000
206
0.010
Why?
Artificial Limbs
1
2003
199
0.010
Why?
Logistic Models
1
2004
2067
0.010
Why?
Models, Biological
1
2006
1773
0.010
Why?
Indians, North American
1
2004
629
0.010
Why?
Interpersonal Relations
1
2002
396
0.010
Why?
Socioeconomic Factors
1
2002
1282
0.010
Why?
Diabetic Neuropathies
1
1998
93
0.010
Why?
Models, Theoretical
1
2000
575
0.010
Why?
Diabetic Retinopathy
1
1998
189
0.010
Why?
Muscle Fibers, Skeletal
1
1996
216
0.010
Why?
Rehabilitation
1
1992
19
0.010
Why?
Cholesterol, HDL
1
1991
203
0.010
Why?
Hydroxybutyrates
1
1989
14
0.010
Why?
Electromyography
1
1992
401
0.010
Why?
3-Hydroxybutyric Acid
1
1989
17
0.010
Why?
Blood Gas Analysis
1
1989
74
0.000
Why?
Nervous System Diseases
1
1992
263
0.000
Why?
Ultrasonics
1
1989
49
0.000
Why?
Action Potentials
1
1992
493
0.000
Why?
Sleep Apnea Syndromes
1
1989
88
0.000
Why?
Drug Combinations
1
1989
343
0.000
Why?
Mice
1
1989
17733
0.000
Why?
Regensteiner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)